Geron Corporation

Healthcare · Biotechnology

1.30$ +1.6% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Geron Corporation (GERN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 519 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet GERN
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	136	130	129	124	114	110	106	183	188	185	176	166	164	166	143	275	286	271	259	252	229	226	198	238	233	191	425	415	413	394	482	449	445	594	562	555	567	571	534	519
Current Assets	115	116	107	102	99	96	91	162	169	166	156	155	142	142	134	221	232	200	215	202	179	187	176	227	222	180	387	377	335	341	452	373	398	491	496	506	522	520	499	486
Cash	5.9	13	15	6.6	9.9	17	7.9	19	13	11	6.8	18	21	14	20	23	45	9.9	32	57	29	35	31	76	61	57	113	57	31	71	190	117	60	79	84	78	78	79	71	63
Cash & Short-Term Investments	109	115	99	95	97	95	90	161	166	164	152	152	139	139	132	219	228	196	211	198	176	184	167	219	195	173	381	371	314	335	443	363	340	407	397	388	381	360	314	301
Receivables	5.4	0.5	0.6	0.5	0.5	0.4	0.6	0.8	0.8	1.2	1.0	0.8	0.8	0.8	0.7	0.8	1.0	0.7	0.8	0.7	0.6	1.8	5.2	4.3	22	3.1	1.6	1.2	15	1.7	1.6	3.1	30	39	34	39	35	39	44	54
Inventory	0.0	-0.5	0.7	0.8	0.0	-0.4	0.0	0.0	0.0	-1.2	–	–	–	-0.8	-0.7	–	–	-0.7	–	–	–	-1.4	–	–	-22	-3.1	-1.6	0.5	0.5	0.0	–	0.8	20	39	56	69	95	117	133	124
Property, Plant & Equipment	0.2	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.4	0.7	0.7	0.7	0.7	0.6	5.6	0.6	0.7	0.6	0.6	0.7	0.8	1.1	5.0	4.9	–	–	–	–	–	–	–	–	–	–	–
Goodwill	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Liabilities	7.3	7.9	12	11	6.0	6.5	4.4	4.9	4.5	7.6	6.3	9.2	12	30	22	24	53	60	57	76	78	100	101	96	124	111	99	117	122	146	137	143	153	313	294	296	319	345	305	300
Current Liabilities	7.3	7.9	12	11	6.0	6.5	4.4	4.9	4.5	7.6	6.3	9.2	12	28	17	19	24	31	29	37	38	46	47	47	83	77	44	73	89	108	123	104	138	88	63	64	88	112	74	70
Short-Term Debt	–	–	–	–	–	–	–	–	–	–	0.6	0.4	0.3	0.4	0.8	0.9	0.9	0.9	0.9	0.9	0.9	0.9	0.9	6.1	14	22	0.9	12	23	48	72	48	73	1.0	1.0	1.0	1.0	19	20	1.0
Accounts Payable	0.3	0.2	0.3	0.2	0.3	0.5	0.5	0.5	0.2	1.0	0.9	1.2	2.0	1.2	3.4	3.8	3.7	6.9	4.5	3.8	4.7	6.7	6.2	4.5	8.2	10	3.4	7.7	14	6.2	10.0	5.6	14	8.6	8.0	8.2	11	11	13	8.8
Long-Term Debt	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	24	24	24	34	35	50	50	45	38	30	51	41	30	35	11	37	12	118	119	119	119	120	120	120
Shareholders' Equity	129	122	117	113	108	104	101	178	183	178	169	157	152	135	121	251	233	211	201	176	152	126	97	142	108	80	326	298	291	248	345	307	292	280	268	260	249	226	229	219
Retained Earnings	-949	-958	-965	-972	-978	-986	-992	-999	-1,004	-1,011	-1,022	-1,036	-1,051	-1,080	-1,096	-1,112	-1,132	-1,156	-1,183	-1,213	-1,240	-1,272	-1,302	-1,330	-1,371	-1,414	-1,452	-1,501	-1,546	-1,598	-1,653	-1,721	-1,747	-1,772	-1,792	-1,809	-1,827	-1,856	-1,859	-1,876
Shares Outstanding	159	159	159	159	159	159	161	174	184	186	186	187	189	198	200	247	319	319	324	327	329	331	332	404	405	408	544	547	580	595	603	654	662	646	666	666	667	667	669	671

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings